Navigation Links
UK public misled over downgrading cannabis: Govt

THE PUBLIC was misled about the dangers of taking cannabis when the Government unwittingly // decided to downgrade the drug less than a year ago, the British Home Secretary admits today.

In a highly critical assessment of the decision taken by his predecessor, David Blunkett, Charles Clarke said he is “very worried” about recent evidence suggesting a strong link between cannabis and mental illness. He made these damning remarks in an interview with The Times, just weeks before he must decide whether or not to execute an embarrassing about-turn and restore the drug’s Class B status.

Clarke said there was an alarming lack of knowledge about the health dangers posed by the drug among the general public. He also admitted that many people had been left confused by the law change. “Whatever happens after this, there will be a renewed commitment to public education about the potential affects of the consumption of cannabis, and its legal status.

Asked specifically if the confusion was a result of Blunkett’s decision to downgrade the drug, he said people did not understand the impact and legal consequences of consumption of cannabis. Over Christmas, Clarke read the report from a special advisory group he set up to assess the latest medical evidence, and shall discuss its findings with colleagues this week before making a final decision.

Leaks of the report suggest the Advisory Committee says use of the drug is clearly linked to mental illness, but stops short of recommending reclassification. Clarke said he is most worried (on the downgrading of cannabis) about the confusion among the punters about the legal status of cannabis.

The drug was downgraded in the hope that it would allow the police to focus on more serious drug abuse. Clarke said it was significant how many advocates of the change had had second thoughts.

Although an about-turn would be embarrassing, it may cause the Labour fewer problems in the long run. Mr Clarke will champion curbs on antisocial behavior this year, which strategists say is undermined by a soft approach to cannabis.


Related medicine news :

1. Controversial deal on public access of the human genome map
2. Czech Republic struck by fifth bird flu incident
3. Biotech Osiris to go public
4. Educating the public about E-coli
5. Ad Campaign Targeting Republicans On Medicare Prescription Drug Program
6. Dengue Kills 40 in Dominican Republic
7. Rift Valley Fever in the United Republic of Tanzania
Post Your Comments:

(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: